Davunetide for Progressive Supranuclear Palsy: a multicenter, randomized, double-blind, placebo controlled trial

BACKGROUND: Davunetide (AL-108, NAP) is an eightamino acid peptide that promotes microtubule stability and decreases tau phosphorylation in pre-clinical studies. Since PSP is tightly linked to tau pathology, davunetide could be an effective treatment for PSP.The goals of this study were to evaluate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Boxer, Adam L., Lang, Anthony E., Grossman, Murray, Knopman, David S., Miller, Bruce L., Schneider, Lon S., Doody, Rachelle S., Lees, Andrew, Golbe, Lawrence I., Williams, David R., Corvol, Jean-Cristophe, Ludolph, Albert, Burn, David, Lorenzl, Stefan, Litvan, Irene, Roberson, Erik D., Höglinger, Günter U., Koestler, Mary, Jack, Clifford R., Van Deerlin, Viviana, Randolph, Christopher, Lobach, Iryna V., Heuer, Hilary W., Gozes, Illana, Parker, Lesley, Whitaker, Steve, Hirman, Joe, Stewart, Alistair J., Gold, Michael, Morimoto, Bruce H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4129545/
https://ncbi.nlm.nih.gov/pubmed/24873720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(14)70088-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky